U.S. News & World Report evaluates the top marijuana-focused exchange-traded funds for 2024, providing investors with a data-driven look at the funds best positioned to capture upside from a potential federal cannabis reform cycle.
The analysis weighs holdings diversification, expense ratios, and exposure to cannabis companies at various stages of the regulatory landscape, with expert commentary from SIVA’s Avis Bulbulyan.
WE DO NOT OWN THIS CONTENT – IT WAS COPIED FROM U.S. News & World Report